SCHEMBL16155403

SCHEMBL16155403

CN[C@@H]1[C@@H](O)[C@H](C)O[C@H](COC(=O)c2ccccc2)[C@H]1O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.46
HTT P42858 1/20 0.44
POLB P06746 2/20 0.42
GAA P10253 1/20 0.42
MAPK1 P28482 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
CHRNB2 P17787 1/20 0.41
CHRNA5 P30532 1/20 0.41
CHRNA7 P36544 1/20 0.41
CHRNA4 P43681 1/20 0.41
HPGD P15428 1/20 0.41
CARM1 Q86X55 1/20 0.40
PRMT6 Q96LA8 1/20 0.40
SYNJ2 O15056 3/20 0.39
TYMP P19971 1/20 0.39
LGALS9 O00182 1/20 0.39
LGALS1 P09382 1/20 0.39
LGALS3 P17931 1/20 0.39
LGALS7; LGALS7B P47929 1/20 0.39
LMNA P02545 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22684921 0.88 ALDH1A1 (0.46) ALDH1A1HTTPOLBGAAMAPK1
SCHEMBL20691410 0.87 ALDH1A1 (0.51) ALDH1A1HTTPOLBGAAMAPK1
SCHEMBL12886328 0.85 ALDH1A1 (0.50) ALDH1A1HTTPOLBGAAMAPK1
SCHEMBL19518777 0.85 ALDH1A1 (0.44) ALDH1A1HTTPOLBGAAMAPK1
SCHEMBL19518850 0.84 ALDH1A1 (0.49) ALDH1A1HTTPOLBGAAMAPK1
SCHEMBL12959081 0.82 ALDH1A1 (0.57) ALDH1A1HTTPOLBGAAMAPK1
SCHEMBL19518958 0.82 ALDH1A1 (0.47) ALDH1A1HTTPOLBGAAMAPK1
SCHEMBL18385918 0.82 ALDH1A1 (0.49) ALDH1A1HTTPOLBGAAMAPK1
SCHEMBL20691412 0.81 ALDH1A1 (0.48) ALDH1A1HTTPOLBGAAMAPK1
SCHEMBL18392650 0.81 SYNJ2 (0.44) ALDH1A1HTTHPGDCARM1PRMT6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9982005-B2 Macrolides and methods of their preparation and use PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2018-05-29 US disclosed
US-20170305953-A1 14-MEMBERED KETOLIDES AND METHODS OF THEIR PREPARATION AND USE PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2017-10-26 US disclosed
WO-2016057798-A1 14-MEMBERED KETOLIDES AND METHODS OF THEIR PREPARATION AND USE PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2016-04-14 WO disclosed
WO-2014165792-A2 MACROLIDES AND METHODS OF THEIR PREPARATION AND USE PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2014-10-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170305953-A1 14-MEMBERED KETOLIDES AND METHODS OF THEIR PREPARATION AND USE CYP51A1, HSD17B7, CYP11B1 ALDH1A1 1733/4885HTT 3523/4885POLB 2749/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.